Marketplace · Belgium
Dental practices businesses in Wavre typically transact at 4.8x-7.0x EV/EBITDA, with a sector median of 5.8x in Belgium. Walloon Brabant's prosperous hub, anchored by pharma (GSK) and professional services.
Wavre (population ~34,000, Walloon Brabant) anchors dental practices transactions at a 5.8x EV/EBITDA median, with most defensible deals landing between 4.8x (conservative) and 7.0x (strong recurring revenue). Walloon Brabant's prosperous hub, anchored by pharma (GSK) and professional services. SME flow skews to high-value services, life-sciences suppliers and consulting; deal multiples trend above the Walloon average.
Upswitch is anonymity-by-design: new dental practices dossiers in Wavre surface here as soon as they pass advisor validation. Subscribe to the alert and we'll notify you within hours of the next listing going live.
Browse all listingsFor a dental practices SME in Wavre with normalised EBITDA above €200k, expect the headline price to anchor on a 5.8x EV/EBITDA multiple, with a working-capital peg, 5-15% escrow, and (in 35-45% of deals) an earn-out tied to year-one EBITDA or customer retention. Cross-border buyer interest from Dutch acquirers is consistently elevated.
Walloon Brabant's prosperous hub, anchored by pharma (GSK) and professional services. SME flow skews to high-value services, life-sciences suppliers and consulting; deal multiples trend above the Walloon average. For dental practices specifically, Wavre's buyer pool typically includes regional family businesses, Benelux-wide strategic acquirers, and (for deals above ~€2m EV) PE-backed roll-up platforms.